Matrix metalloproteinase-3-dependent generation of a macrophage chemoattractant in a model of herniated disc resorption

Journal of Clinical Investigation

Volumn 105, Issue 2, 2000, Pages 133-141

  Haro, Hirotaka ^a,b   Crawford, Howard C ^b   Fingleton, Barbara ^b   MacDougall, John R ^b   Shinomiya, Kenichi ^c   Spengler, Dan M ^a   Matrisian, Lynn M ^b  

^a VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^b VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

MATRILYSIN; PROTEOGLYCAN; STROMELYSIN;

ANIMAL CELL; ARTICLE; CARTILAGE CELL; CELL INFILTRATION; CELL INTERACTION; CHEMOTAXIS; CHONDROLYSIS; COCULTURE; CONTROLLED STUDY; INTERVERTEBRAL DISK HERNIA; MODEL; MOUSE; NONHUMAN; PERITONEUM MACROPHAGE; PRIORITY JOURNAL; PROTEIN EXPRESSION;

EID: 0033966204     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI7090     Document Type: Article

References (51)

1. Frymoyer, J.W., and Cats-Baril, W.L. 1991. An overview of the incidence and costs of low back pain. Orthop. Clin. N. Am. 22:263-271.
2. Borenstein, D. 1996. Epidemiology, etiology, diagnostic evaluation, and treatment of low back pain. Curr. Opin. Rheumatol. 8:124-129.
3. Cypress, B.K. 1983. Characteristics of physician visits for back symptoms: a national perspective. Am. J. Public Health. 73:389-395.
4. Deyo, R.A., and Tsui-wu, Y.-J. 1987. Descriptive epidemiology of low-back pain and its related medical care in the united states. Spine. 12:264-268.
5. Anderson, G.B.J., and Weinstein, J.N. 1996. Disc herniation [editorial]. Spine. 21(Suppl. 24):1S.
6. Roberts, S., Caterson, B., Evans, H., and Eisenstein, S.M. 1994. Proteoglycan components of the intervertebral disc and cartilage endplate: an immunolocalization study of animal and human tissues. Histochem. J. 26:402-411.
7. Eyre, D.R., and Muir, H. 1976. Types I and II collagens in intervertebral disc: interchanging radial distributions in annulus fibrosus. Biochem. J. 157:267-270.
8. Eyre, D.R., and Muir, H. 1977. Quantitative analysis of type I and II collagens in human intervertebral discs at various ages. Biochim. Biophys. Acta. 492:29-42.
9. Nerlich, A.G., Boos, N., Wiest, I., and Aebi, M. 1998. Immunolocalization of major interstitial collagen types in human lumbar intervertebral discs of various ages. Virchows Arch. 432:67-76.
10. Lipson, S.J., and Muir, H. 1981. Experimental intervertebral disc degeneration: morphologic and proteoglycan changes over time. Arthritis Rheum. 24:12-21.
11. Wisneski, R.J., Garfin, S.R., and Rothman, R.H. 1992. Lumbar disc disease. In The spine. 3rd edition. R.H. Rothman and F.A. Simeone, editors. W.B. Saunders Co. Philadelphia, PA. 671.
12. Haro, H., et al. 1996. Upregulated expression of chemokines in herniated nucleus pulposus resorption. Spine. 21:647-652.
13. Frymoyer, J.W. 1988. Back pain and sciatica. N. Engl. J. Med. 318:291-300.
14. Komori, H., et al. 1996. The natural history of herniated nucleus pulposus with radiculopathy. Spine. 21:225-229.
15. Komori, H., et al. 1998. Contrast-enhanced magnetic resonance imaging in conservative management of lumbar disc herniation. Spine. 23:67-73.
16. Bonassar, L.J., et al. 1995. Changes in cartilage composition and physical properties due to stromelysin degradation. Arthritis Rheum. 38:173-183.
17. Fosang, A.J., et al. 1992. The interglobular domain of cartilage aggrecan is cleaved by PUMP, gelatinases, and cathepsin B. J Biol. Chem. 267:19470-19474.
18. Haro, H., Shinomiya, K., Murakami, S., and Spengler, D.M. 1999. Up-regulated expression of matrilysin and neutrophil collagenase in human herniated discs. J. Spinal Disord. 13:245-249.
19. Kanemoto, M., Hukuda, S., Komiya, Y., Katsuura, A., and Nishioka, J. 1996. Immunohistochemical study of matrix metalloproteinase-3 and tissue inhibitor of metalloproteinase-1 in human intervertebral discs. Spine. 21:18.
20. Haro, H., Murakami, S., Komori, H., Okawa, A., and Shinomiya, K. 1997. Chemonucleolysis with human stromelysin-1. Spine. 22:1098-1104.
21. Ohta, S., et al. 1998. Expression of matrix metalloproteinase 7 (matrilysin) in human osteoarthritic cartilage. Lab Invest. 78:79-87.
22. Okada, Y., Takeuchi, N., Tomita, K., Nakanishi, I., and Nagase, H. 1989. Immunolocalisation of matrix metalloproteinase 3 (stromelysin) in rheumatoid synovioblasts (B cells): correlation with rheumatoid arthritis. Ann. Rheum. Dis. 48:645-653.
23. Okada, Y., et al. 1992. Localization of matrix metalloproteinase 3 (stromelysin) in osteoarthritic cartilage and synovium. Lab. Invest. 66:1069-1073.
24. Mudgett, J.S., et al. 1998. Susceptibility of stromelysin 1-deficient mice to collagen-induced arthritis and cartilage destruction. Arthritis Rheum. 41:110-121.
25. Wilson, C.L., Heppner, K.J., Labosky, P.A., Hogan, B.L.M., and Matrisian, L.M. 1997. Intestinal tumorigenesis is suppressed in mice lacking the metalloproteinase matrilysin. Proc. Natl. Acad. Sci. USA. 94:1402-1407.
26. Grigoriadis, A.E., Aubin, J.E., and Heersche, J.N. 1989. Effects of dexamethasone and vitamin D3 on cartilage differentiation in a clonal chondrogenic cell population. Endocrinology. 125:2103-2110.
27. Laurence, R. 1971. Chemical basis for the histological use of Safranin O in the study of articular cartilage. J. Bone Joint Surg. Am. 53:69-82.
28. Wright, J.H., et al. 1994. A switch from stromal to tumor cell expression of stromelysin-1 mRNA associated with the conversion of squamous to spindle carcinomas during mouse skin tumor progression. Mol. Carcinog. 10:207-215.
29. Matrisian, L.M., et al. 1986. The mRNA coding for the secreted protease transin is expressed more abundantly in malignant than in benign tumors. Proc. Natl. Acad. Sci. USA. 83:9413-9417.
30. Wilson, C.L., Heppner, K.J., Rudolph, L.A., and Matrisian, L.M. 1995. The metalloproteinase matrilysin is preferentially expressed by epithelial cells in a tissue-restricted pattern in the mouse. Mol. Biol. Cell. 6:851-869.
31. Chomczynski, P., and Sacchi, N. 1987. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162:156-159
32. Benya, P.D., and Shaffer, J.D. 1982. Dedifferentiated chondrocytes reexpress the differentiated collagen phenotype when cultured in agarose gels. Cell. 30:215-224.
33. Guo, J., Jourdian, G.W., and MacCallum, D.K. 1989. Culture and growth characteristics of chondrocytes encapsulated in alginate beads. Connect. Tissue Res. 19:277-297.
34. Häuselmann, H.J., et al. 1994. Phenotypic stability of bovine articular chondrocytes after long-term culture in alginate beads. J. Cell Sci. 107:17-27.
35. Chiba, K., Andersson, G.B.J., Masuda, K., and Thonar, E.J. 1997. Metabolism of the extracellular matrix formed by intervertebral disc cells cultured in alginate. Spine. 22:2885-2893.
36. Lowe, G.N., et al. 1996. Effects of prostaglandins on deoxyribonucleic acid and aggrecan synthesis in the RCJ 3.1C5.18 chondrocyte cell line. Endocrinology. 137:2208-2216.
37. Horton, W.E.J., Udo, I., Precht, P., Balakir, R., and Hasty, K. 1998. Cytokine inducible matrix metalloproteinase expression in immortalized rat chondrocytes is independent of nitric oxide stimulation. In Vitro Cell. Dev. Biol. 34:378-384.
38. Fosang, A.J., Last, K., and Maciewicz, R.A. 1996. Aggrecan is degraded by matrix metalloproteinases in human arthritis. Evidence that matrix metalloproteinase and aggrecanase activities can be independent. J. Clin. Invest. 98:2292-2299.
39. Tortorella, M.D., et al. 1999. Purification and cloning of aggrecanase-1: a member of the ADAMTS family of proteins. Science. 284:1664-1666.
40. Sztrolovics, R., Alini, M., Roughley, P.J., and Mort, J.S. 1997. Aggrecan degradation in human intervertebral disc and articular cartilage. Biochem. J. 326:235-241.
41. Baumann, H., and Gauldie, J. 1994. The acute phase response. Immunol. Today. 15:74-80.
42. MacNaul, K.L., Chartrain, N., Lark, M., Tocci, M.J., and Hutchinson, N.I. 1990. Discoordinate expression of stromelysin, collagenase, and tissue inhibitor of metalloproteinases-1 in rheumatoid synovial fibroblasts. Synergistic effects of interleukin-1 and tumor necrosis factor-alpha on stromelysin expression. J. Biol. Chem. 265:17238-17245.
43. Ganu, V.S., et al. 1994. Biochemical and molecular characterization of stromelysin synthesized by human osteoarthritic chondrocytes stimulated with recombinant human interleukin-1. Clin. Exp. Rheumatol. 12:489-496.
44. Haro, H., et al. Matrix metalloproteinase-7 dependent release of tumor necrosis tumor necrosis factor-α in a model of herniated disc resorption. J. Clin. Invest. 105:143-150.
45. Nakashima, Y., et al. 1998. Induction of matrix metalloproteinase expression in human macrophages by orthopaedics particulate debris in vitro. J. Bone Joint Surg. Br. 80:694-700.
46. Mach, F., Schönbeck, U., Bonnefoy, J.-Y., Pober, J.S., and Libby, P. 1997. Activation of monocyte/macrophage functions related to acute atheroma complication by ligation of CD40: induction of collagenase, stromelysin, and tissue factor. Circulation. 96:396-399.
47. Busiek, D.F., et al. 1992. The matrix metalloproteinase matrilysin (PUMP) is expressed in developing human mononuclear phagocytes. J. Biol. Chem. 267:9087-9092.
48. Shapiro, S.D., Kobayashi, D., and Ley, T. 1993. Cloning and characterization of a unique elastolytic metalloproteinase produced by human alveolar macrophages. J. Biol. Chem. 268:23824-23829.
49. Lindy, O., et al. 1997. Matrix metalloproteinase 13 (collagenase 3) in human rheumatoid synovium. Arthritis Rheum. 40:1391-1399.
50. Denhardt, D.T., and Guo, X. 1993. Osteopontin: a protein with diverse functions. FASEB J. 7:1475-1482.
51. Werb, Z. 1997. ECM and cell surface proteolysis: regulating cellular ecology. Cell. 91:439-442.